Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Haematology Other
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Haematology Other
    X-Linked Thrombophilia with a Mutant Factor IX (Factor IX Padua) - (N Engl J Med)
    Postoperative Anticoagulation Therapy Necessary in Patients Following Major Surgery: Presented at ASA - (DGDispatch)
    New USP Standards for Heparin Products Will Result in Decreased Potency - (DGNews)
    Thrombomodulin mutations in atypical hemolytic-uremic syndrome - (N Engl J Med)
    Circulating Blood Cells Are Important Predictors of Cancer Spread in Children - (DGNews)

    News archive

     Recent webcasts/CME - Haematology Other
    • Managing Treatment- and Disease-Related Complications in Multiple Myeloma
    • Thrombosis in Multiple Myeloma: Choice of Thromboprophylaxis Depends on Type of Therapy and Individual Risk of Patient
    • Peripheral Neuropathy in Multiple Myeloma: Early Recognition and Intervention Key to Minimize Long-Term Complications
    • Myeloma Bone Disease: Is Targeting of Osteoclastic and Osteoblastic Mechanisms Necessary for Effective Therapy?
    • PreAnesthetic Assessment of the Patient on Low Dose Aspirin and a Thienopyridine - Part 1

      Webcasts/CME archive

       Recent cases - Haematology Other
        Cobalamin Deficiency Resulting in a Rare Haematological Disorder: A Case Report
        Complications of Evans' Syndrome in an Infant with Hereditary Spherocytosis: A Case Report
        Multisystem Failure Due to Three Coexisting Autoimmune Diseases
        An Unusual Cause of Methaemoglobinaemia
        Vancomycin-Induced Thrombocytopenia in a 60-Year-Old Man: A Case Report

        Cases archive
          




        my personal edition > haematology other > news
        divider

          E-Mail this DGNews to a colleague

        DGNews


        Fatal Medication Errors With Heparin Products

        FDA MedWatch: Heparin Sodium Injection 10,000 units/mL and HEP-LOCK U/P 10 units/mL associated with fatal medication errors

        BETHESDA, MD -- February 8, 2007 -- Baxter and U.S. Food and Drug Administration (FDA) notified healthcare professionals of the potential for life threatening medication errors involving two Heparin products, Heparin Sodium Injection 10,000 units/mL, and HEP-LOCK U/P 10 units/mL.

        Baxter is aware of fatal medication errors that have occurred when two Heparin products with shades of blue labeling were mistaken for each other. Three infant deaths resulted when the higher dosage Heparin Sodium Injection 10,000 units/mL was inadvertently administered instead of the lower dosage of HEP-LOCK U/P 10 units/mL.

        The currently marketed 1 mL vials of both Heparin products use blue as the prominent background color on their labels.


        SOURCE: Food and Drug Administration



        E-Mail this DGNews to a colleague   To print, use this version






        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send